He was 38, couldn’t get through a workday without coffee and sheer willpower, felt like he was recovering from the flu every single morning, and had stopped exercising because he simply didn’t have the reserves for it. Then a new provider ordered an early morning cortisol level. It came back at 4.2 mcg/dL — low enough to warrant a referral to endocrinology, where a cosyntropin stimulation test confirmed secondary adrenal insufficiency. Not adrenal fatigue. Actual, diagnosable, treatable insufficiency.
Three years of symptoms. Three years of being told it was stress and depression. And the answer had been a single blood test away the entire time.
The term “adrenal fatigue” has created enormous confusion in both medicine and wellness culture — confusion that harms patients from two directions at once. From the conventional medicine direction, the concept’s association with unproven wellness claims leads a lot of physicians to dismiss legitimate adrenal-related symptoms without adequate investigation.
From the functional medicine direction, the “adrenal fatigue” label gets applied so broadly, with such low diagnostic standards, that genuinely serious conditions get missed while expensive supplements and vague lifestyle advice stand in for diagnostic rigor. Understanding where real adrenal insufficiency ends and wellness-industry “adrenal fatigue” begins means engaging seriously with the actual endocrinology. Not picking a side and staying there.
The Adrenal Glands: Anatomy, Physiology, and What They Actually Do
The adrenal glands are small, walnut-sized organs sitting atop each kidney, and they produce an extraordinary range of hormones regulating everything from stress response to blood pressure to immune function. Their complexity makes them fascinating. It also means dysfunction shows up in diverse, non-specific ways that make diagnosis genuinely hard.
The adrenal gland splits anatomically and functionally into two distinct zones — the outer cortex and the inner medulla — which are essentially two separate endocrine organs that happen to share a building.
The adrenal cortex (roughly 80% of the gland) produces steroid hormones under control of the hypothalamic-pituitary-adrenal axis. It’s further divided into three concentric layers: the zona glomerulosa, producing mineralocorticoids (primarily aldosterone) that regulate sodium and potassium balance and blood pressure; the zona fasciculata, producing glucocorticoids (primarily cortisol) that regulate glucose metabolism, immune function, stress response, and inflammation; and the zona reticularis, producing adrenal androgens (DHEA and androstenedione) that feed into sex hormone production.
The adrenal medulla (the inner 20%) is developmentally and functionally distinct — an embryological derivative of the neural crest, essentially a modified sympathetic ganglion producing catecholamines (epinephrine and norepinephrine) in response to acute stress. Medullary failure is not the basis of adrenal insufficiency in the usual clinical sense.
Cortisol is the hormone central to both adrenal insufficiency and the “adrenal fatigue” conversation, and its physiology deserves careful attention. Cortisol secretion follows a pronounced circadian rhythm: levels peak sharply in the 30-45 minutes after waking (the cortisol awakening response), then decline gradually through the day, hitting their lowest point in the middle of the night. This circadian pattern is driven by the suprachiasmatic nucleus in the hypothalamus, syncing the HPA axis to the light-dark cycle.
The morning cortisol surge preps the body for the day ahead — mobilizing glucose, reducing inflammation, raising alertness and blood pressure. People who are genuinely adrenal insufficient often describe their worst symptoms in the morning and early afternoon. Precisely when cortisol is supposed to be at its highest.
Primary vs. Secondary Adrenal Insufficiency: A Critical Distinction
Real adrenal insufficiency — actual cortisol deficiency severe enough to need medical treatment — comes in two fundamentally different forms, with different causes, different clinical presentations, and different management. Conflating these two with each other, or with vague “adrenal fatigue,” produces clinical errors with real consequences.
Primary adrenal insufficiency (Addison’s disease) is caused by destruction or dysfunction of the adrenal cortex itself. The glands can’t produce adequate cortisol no matter how much ACTH the pituitary sends. The most common cause in developed countries is autoimmune adrenalitis — the immune system destroying adrenal cortical tissue, much like Hashimoto’s destroys thyroid tissue. Other causes: tuberculosis (historically the leading cause worldwide), other granulomatous diseases, adrenal hemorrhage, metastatic cancer, fungal infections.
In primary adrenal insufficiency, both cortisol AND aldosterone deficiency occur, because the cortex itself is damaged. That produces a characteristic clinical picture: profound fatigue, weight loss, nausea, hyperpigmentation (elevated ACTH drives pigmentation through MSH cross-reactivity), hyponatremia, hyperkalemia, hypotension. Addison’s disease is a medical emergency when untreated — adrenal crisis produces life-threatening hypotension, hypoglycemia, cardiovascular collapse.
Secondary adrenal insufficiency comes from insufficient ACTH production by the pituitary, which then fails to stimulate the adrenal cortex adequately. The adrenal glands themselves are structurally intact — just insufficiently signaled. The most common cause is iatrogenic: exogenous glucocorticoid use (prednisone, dexamethasone, high-dose inhaled fluticasone, extensively used topical steroids) suppresses the HPA axis over time.
When steroids get stopped abruptly after prolonged use, the axis hasn’t recovered yet, and cortisol production stays inadequate.
This is one of the most common, and most underrecognized, causes of adrenal insufficiency in clinical practice. Other causes of secondary insufficiency: pituitary adenomas, head trauma, pituitary apoplexy, infiltrative diseases, cranial irradiation.
In secondary adrenal insufficiency, aldosterone production is largely preserved — it’s mostly regulated by the renin-angiotensin system, not ACTH — so the classic hyponatremia/hyperkalemia/hyperpigmentation picture of primary insufficiency is absent. Which makes secondary insufficiency subtler clinically, and more often missed.
What “Adrenal Fatigue” Claims and Why the Diagnosis Is Controversial
The term “adrenal fatigue” was popularized mainly by Dr. James Wilson in his 2001 book, referring to a proposed syndrome of suboptimal adrenal function caused by chronic stress — a state below frank insufficiency but above normal function, showing up as fatigue, difficulty waking, afternoon energy crashes, salt cravings, difficulty handling stress, impaired immune function.
The theoretical mechanism: chronic psychological and physiological stress persistently activates the HPA axis, leading to prolonged cortisol secretion that eventually “exhausts” the adrenal glands’ capacity, dropping cortisol output below optimal even though lab values stay technically “normal.” The diagnosis is typically made by alternative and functional medicine practitioners using salivary cortisol testing — four or more collection points through the day — to identify patterns of “low” or “blunted” cortisol response.
The mainstream endocrinological rejection of this diagnosis rests on a few grounds. First, there’s no pathological evidence for “adrenal exhaustion” from chronic stress in humans — studies of chronically stressed people (caregivers, shift workers, war veterans) find dysregulated HPA axis responses, but not reduced adrenal cortisol capacity. What actually shows up more often in chronic stress and burnout is HPA hyperreactivity and altered circadian cortisol rhythms. Not uniform cortisol deficiency.
Second, salivary cortisol testing, while a legitimate research tool, doesn’t have standardized reference ranges, validated clinical cut-offs for diagnosis, or established treatment algorithms in clinical practice. Third, no large controlled clinical trials have established either the existence of “adrenal fatigue” as a distinct biological entity or the efficacy of any treatment for it.
A 2016 systematic review in BMC Endocrine Disorders by Cadegiani and Kater examined all published literature on “adrenal fatigue” and concluded there was “no substantiation that ‘adrenal fatigue’ is an actual medical condition” based on the available evidence. That’s the mainstream endocrinological consensus, plainly stated.
But complete dismissal of stress-related HPA dysregulation as clinically irrelevant overcorrects. Burnout, chronic fatigue syndrome/myalgic encephalomyelitis, post-traumatic stress disorder, and chronic inflammatory states all involve documented alterations in HPA axis function — changes to the cortisol awakening response, flattened diurnal cortisol curves, altered cortisol sensitivity — that are biologically meaningful even if they don’t add up to “adrenal insufficiency” in the endocrinological sense. The error in “adrenal fatigue” isn’t that stress affects cortisol dynamics.
It’s stretching a real phenomenon into a false diagnostic category, then treating it with supplements that lack evidence.
Diagnosing Real Adrenal Insufficiency: The Tests That Matter
Morning serum cortisol (drawn between 8-9 AM, when cortisol should be at or near its peak) is the right initial screening test for adrenal insufficiency. A morning cortisol above 18 mcg/dL effectively rules out significant adrenal insufficiency. Below 3 mcg/dL strongly suggests it. The gray zone of 3-18 mcg/dL needs dynamic testing to resolve.
The cosyntropin (ACTH) stimulation test — the gold standard for primary adrenal insufficiency diagnosis — administers 250 mcg of synthetic ACTH intravenously and measures serum cortisol at 0, 30, and 60 minutes. Normal adrenal response: cortisol rising above 18-20 mcg/dL at 30 or 60 minutes. Failure to hit that rise confirms adrenal insufficiency.
The standard 250 mcg test is optimally sensitive for primary insufficiency; a 1 mcg low-dose cosyntropin test may be more sensitive for secondary insufficiency, though interpretation gets more complex and the test is less standardized.
Plasma ACTH measurement distinguishes primary from secondary insufficiency. In primary adrenal insufficiency, ACTH runs elevated — the pituitary is screaming at dysfunctional adrenal glands to produce more cortisol. In secondary insufficiency, ACTH is low or inappropriately normal — the pituitary is the actual problem.
Twenty-four-hour urinary free cortisol and salivary cortisol profiles are useful research tools but have real limitations for diagnosing insufficiency in clinical practice. The 24-hour urinary cortisol reflects integrated production over the day but is insensitive for detecting mild insufficiency. Midnight salivary cortisol is used diagnostically for Cushing’s syndrome — cortisol excess — not deficiency. Salivary profiles across the day capture the circadian pattern but don’t diagnose insufficiency by established clinical criteria.
Timing matters a lot when ordering these tests. Morning cortisol should be drawn as close to 8 AM as possible — a 10 AM draw can run 20-30% lower than an 8 AM draw in healthy people, creating false concern. Illness, recent surgery, emotional distress, and acute physical stress all appropriately elevate cortisol — testing during these windows produces misleadingly “normal” results even in patients with genuine insufficiency. Testing should happen in a stable clinical state, not mid-crisis.
When to Suspect Secondary Adrenal Insufficiency in Practice
Secondary adrenal insufficiency from exogenous steroid use is dramatically underrecognized in clinical practice, because both patients and providers systematically underestimate how HPA-suppressive “routine” corticosteroid prescribing actually is.
Prolonged oral prednisone at 5 mg/day or higher for more than 3-4 weeks causes significant HPA axis suppression. High-dose inhaled fluticasone (particularly above 1000 mcg/day) can cause clinically meaningful HPA suppression too, and it’s frequently missed because inhalation gets assumed to be “just local” therapy — but systemic absorption is real and dose-dependent. Intranasal fluticasone propionate (Flonase and equivalents) at standard doses has minimal HPA effect, but combining multiple topical and inhaled steroids adds up.
Long-term topical corticosteroid use over large body surface areas — treating widespread eczema or psoriasis — has caused documented adrenal suppression in case series, particularly in children and the elderly.
The clinical pattern that should raise suspicion of secondary insufficiency from steroid use: fatigue, weakness, nausea, lightheadedness on standing, poor stress tolerance in a patient with a history of steroid treatment — particularly in the weeks to months after a steroid dose reduction or discontinuation. This warrants early morning cortisol testing and, if abnormal, cosyntropin stimulation testing. Management is controlled steroid withdrawal with HPA axis monitoring and physiological steroid coverage during intercurrent illness — sick day rules.
Autoimmune polyglandular syndromes are another important context for secondary insufficiency. APS Type 2 — the combination of Addison’s disease, autoimmune hypothyroidism, and Type 1 diabetes — is an established syndrome where multiple endocrine glands get targeted by the same autoimmune process. A patient with Hashimoto’s or Type 1 diabetes who develops unexplained fatigue, weight loss, and particularly hyperpigmentation or postural hypotension should be evaluated for concurrent adrenal autoimmunity, with morning cortisol and 21-hydroxylase antibodies — the autoantibodies specific to autoimmune adrenalitis.
Treatment of Adrenal Insufficiency: What Replacement Therapy Actually Involves
Once real adrenal insufficiency is confirmed, treatment means glucocorticoid replacement to supply the cortisol the adrenal glands can no longer make. This is life-sustaining therapy, and it requires understanding beyond just taking a pill daily.
Hydrocortisone (cortisol itself) is the preferred replacement for most patients. The regimen is built to imitate the body’s own curve rather than simply to supply the hormone: an endocrinologist sets a total for the day and divides it into two or three separate doses, weighted heaviest on waking and tapering through a midday dose and a late-afternoon one. The shape matters as much as the total. Taking the whole day’s amount in one morning dose doesn’t replicate the physiological pattern, and it leaves a lot of patients with afternoon energy crashes.
Modified-release hydrocortisone (Plenadren, available in some countries) is formulated specifically to give a cortisol pharmacokinetic profile closer to physiological secretion — a higher morning peak, a prolonged gradual decline. Clinical trials comparing modified-release to immediate-release hydrocortisone show improvements in quality of life, metabolic markers, and HbA1c in adrenal insufficiency patients. Not available in the United States as of 2024, but available in Europe and Canada.
In primary adrenal insufficiency (Addison’s disease), aldosterone replacement is also required, provided by fludrocortisone (Florinef) — a synthetic mineralocorticoid. Fludrocortisone maintains sodium and potassium balance and supports blood pressure. Signs of under-replacement: salt craving, dizziness on standing, high potassium. Signs of over-replacement: hypertension, fluid retention, low potassium.
Sick day rules are critical, life-saving knowledge for adrenal insufficient patients. During illness, surgery, trauma, or any physical stress, cortisol requirements jump substantially — healthy people mount a cortisol stress response that doubles or triples output. People with adrenal insufficiency can’t mount that response on their own and have to raise their own hydrocortisone to stand in for it — the “sick day rule”: doubling or tripling the usual amount during intercurrent illness, and moving to more frequent dosing through the day, with a further increase for high fever or trauma. The specific amounts sit in the written sick day protocol an endocrinologist issues ahead of time, worked out in advance precisely so that nobody has to calculate while sick.
Without stress dosing during illness, adrenal crisis — potentially fatal circulatory collapse — can develop. All adrenal insufficient patients should carry an emergency injectable hydrocortisone kit (Solu-Cortef emergency kit) and wear medical alert identification. Providers, emergency personnel, and family members should all be educated on adrenal crisis management, not just the patient.
The Overlap: Conditions That Genuinely Cause HPA Dysregulation
Burnout — the clinical syndrome of exhaustion, cynicism, and reduced professional efficacy from chronic occupational stress — is associated with documented changes in HPA axis function. Studies using cortisol awakening response measurement in burnout consistently find a blunted CAR compared to controls — a lower morning cortisol spike than healthy individuals. Total daily cortisol may be normal or low-normal, but the circadian pattern is flattened.
This isn’t “adrenal fatigue” in the sense of reduced adrenal capacity, but it is genuine HPA dysregulation affecting energy regulation. Treatment: addressing the occupational and psychological drivers of burnout, sleep optimization, exercise, and in some cases psychological therapy. Not cortisol supplements.
Chronic fatigue syndrome/myalgic encephalomyelitis involves well-documented HPA axis abnormalities — reduced cortisol production in response to exercise, altered CRH stimulation tests, atypical cortisol patterns. These findings don’t meet criteria for adrenal insufficiency, but they represent genuine neuroendocrine dysfunction contributing to the symptom complex. CFS/ME is a distinct, serious condition that requires specialized management and shouldn’t be attributed to “adrenal fatigue” — nor should its genuine neuroendocrine component get dismissed just because the associated label is problematic.
Post-COVID syndrome (Long COVID) increasingly shows evidence of HPA axis dysregulation, with some studies finding blunted cortisol awakening responses and altered cortisol reactivity. SARS-CoV-2 can directly affect the hypothalamus and pituitary through neuroinvasion, and the post-acute inflammatory state may affect HPA function through cytokine-mediated mechanisms. Several cases of new-onset secondary adrenal insufficiency following COVID-19 have been reported, and patients with persistent post-COVID fatigue warrant morning cortisol screening as part of their workup.
PTSD involves some of the most extensively studied HPA axis alterations. Contrary to the general “chronic stress raises cortisol” model, PTSD is often associated with reduced cortisol — low-normal cortisol paired with heightened glucocorticoid receptor sensitivity. That paradoxical low-cortisol-but-high-stress-response pattern reflects the complex adaptation of the HPA axis to chronic trauma. These cortisol abnormalities contribute to the immune dysregulation, metabolic effects, and fatigue seen in PTSD — but again, not through “adrenal exhaustion,” and not something adrenal supplements touch.
The Supplement Industry and “Adrenal Support”: What to Know
The “adrenal fatigue” diagnosis has spawned a substantial supplement industry, and understanding what these products actually contain, and what evidence supports them — remarkably little — matters for patients and clinicians alike.
“Adrenal support” supplements typically combine: adaptogenic herbs (ashwagandha, rhodiola rosea, Siberian ginseng, licorice root); B vitamins; vitamin C; pantothenic acid; adrenal glandular extracts (desiccated adrenal tissue from bovine or porcine sources); and various proprietary blends. Claims run toward “supporting healthy cortisol levels,” “reducing stress response,” “supporting adrenal function.”
The evidence for adaptogens — herbs claimed to “normalize” the stress response — is a mixed bag. Ashwagandha (Withania somnifera) has multiple randomized controlled trials showing modest reductions in self-reported stress, modest reductions in morning cortisol, and improvements in anxiety scores in chronically stressed adults. Real effects. Modest effect sizes, though. A 2019 meta-analysis of 7 ashwagandha RCTs found consistent cortisol reduction and stress score improvement.
Rhodiola rosea has some evidence for fatigue reduction in burnout and stress scenarios. Both of these adaptogens carry a reasonable safety profile at standard doses, though liver toxicity cases have been reported with high-dose ashwagandha, and drug interactions with CYP3A4 substrates are possible.
Licorice root is one of the more pharmacologically active “adrenal support” ingredients — glycyrrhizin, the active compound, inhibits 11-beta-hydroxysteroid dehydrogenase type 2, the enzyme that inactivates cortisol in peripheral tissues. This effectively raises cortisol activity without raising serum cortisol. At the doses found in supplements, this effect is real enough to cause hypertension, hypokalemia, and fluid retention in susceptible people. Licorice root should be used with extreme caution, particularly for people with hypertension, cardiac disease, or anyone on antihypertensive medication.
Adrenal glandular extracts — dried bovine or porcine adrenal tissue — have theoretical potential to contain low levels of biologically active cortisol. Some preparations have been found on independent testing to contain measurable quantities of glucocorticoids. Which creates a specific risk: unregulated “adrenal support” supplements with glandular extracts may contain pharmacologically active steroid doses that suppress the patient’s own HPA axis, or cause iatrogenic Cushing’s syndrome at higher doses.
This isn’t hypothetical. Case reports exist of glandular supplement users developing Cushing’s features.
Lifestyle Factors and HPA Axis Health: Evidence-Based Approaches
For people with documented HPA dysregulation — from burnout, post-COVID, chronic stress, or CFS/ME — genuine lifestyle interventions exist with real evidence for normalizing HPA axis function and improving the cortisol patterns that affect energy and stress resilience.
Sleep timing and quality have direct, powerful effects on cortisol circadian rhythms. The cortisol awakening response needs proper circadian entrainment to the light-dark cycle — people whose sleep timing is misaligned with their chronotype (night owls forced into early schedules, shift workers) have blunted or poorly timed CAR. Light exposure right on waking — morning sunlight for 10-15 minutes, or a 10,000 lux light therapy box — supports cortisol awakening response amplitude through SCN activation.
Consistent sleep-wake timing (within 30 minutes daily, weekends included) is the single most impactful circadian intervention for normalizing cortisol rhythm.
Exercise has complex, dose-dependent effects on HPA axis function. Moderate-intensity aerobic exercise acutely activates the HPA axis — cortisol rises during exercise — but improves HPA feedback regulation and reduces baseline cortisol over time in regular exercisers, presumably through improved negative feedback sensitivity. High-volume endurance training without adequate recovery — overtraining syndrome — can cause HPA blunting similar to burnout, a well-documented phenomenon in competitive athletes.
The dose matters: moderate, sustainable exercise supports HPA health. Excessive training without recovery impairs it.
Mind-body practices — mindfulness-based stress reduction, yoga, tai chi, progressive muscle relaxation, diaphragmatic breathing — have RCT-level evidence for modulating HPA axis function. A 2014 meta-analysis of 20 RCTs found MBSR significantly reduced salivary cortisol, with effect sizes varying by population and program intensity. Yoga RCTs consistently show reductions in morning cortisol and improvements in cortisol awakening response amplitude.
These practices work partly through parasympathetic activation (improved vagal tone) and partly through cognitive reappraisal reducing the perceived stressfulness of stressors — both of which cut down the frequency and magnitude of HPA axis activation.
Caffeine timing deserves specific mention because of its direct HPA axis effects. Caffeine activates the sympathoadrenal system and amplifies the cortisol awakening response when consumed in the morning. Coffee within the first 90 minutes after waking blunts subsequent afternoon cortisol production — negative feedback from the morning spike.
Delaying caffeine until 90-120 minutes after waking — letting the natural cortisol awakening response drive morning energy before adding caffeine on top — is a practice backed by chronobiology research that improves afternoon energy stability and cuts down the characteristic mid-afternoon crash early-morning coffee drinkers get.
Common Questions About Adrenal Glands Anatomy
How do I know if I have adrenal fatigue or real adrenal insufficiency?
The fundamental distinction requires proper diagnostic testing. A morning serum cortisol (drawn 8-9 AM) is the right initial test. Values above 18 mcg/dL effectively rule out significant adrenal insufficiency. Values below 3-5 mcg/dL strongly suggest it. Values in the 5-18 mcg/dL range warrant a cosyntropin (ACTH) stimulation test, performed by an endocrinologist. “Adrenal fatigue” is typically diagnosed by alternative practitioners using salivary cortisol patterns that fall outside clinical diagnostic criteria but don’t reach the threshold for true insufficiency.
If you have fatigue and haven’t had a morning serum cortisol drawn, you haven’t actually been evaluated for adrenal issues yet. If your morning serum cortisol was normal and cosyntropin stimulation was normal, you don’t have adrenal insufficiency — regardless of what alternative testing shows.
Can chronic stress actually damage the adrenal glands?
The evidence doesn’t support “adrenal gland damage” from chronic psychological stress in otherwise healthy adults. Studies of chronically stressed populations (long-term caregivers, workers in high-demand jobs, war veterans) consistently show HPA axis dysregulation — altered cortisol patterns, blunted awakening responses, changed feedback sensitivity — but not reduced adrenal cortisol production capacity or structural adrenal damage. The adrenal glands are tough organs.
What changes with chronic stress is the central regulation of the HPA axis, in the hypothalamus and pituitary, not the adrenal glands themselves. Which is exactly why “adrenal support” supplements targeting the adrenal glands are misframing the problem from the start.
What are the symptoms of an adrenal crisis?
Adrenal crisis is a medical emergency where cortisol levels drop acutely to dangerously low levels, typically during illness, trauma, or surgery in a patient with adrenal insufficiency. Symptoms: severe weakness and fatigue, abdominal pain, nausea and vomiting, diarrhea, severe hypotension, dizziness, confusion, loss of consciousness. In a known adrenal insufficient patient who can’t take oral medications due to vomiting, immediate parenteral hydrocortisone (100 mg IV or IM) is life-saving and should not be delayed for any reason.
Emergency departments treating known adrenal insufficient patients with significant illness should administer stress-dose steroids without waiting on labs.
Do adrenal “adaptogens” like ashwagandha and rhodiola actually work?
For reducing subjective stress and modestly lowering morning cortisol in chronically stressed but otherwise healthy adults, ashwagandha has the most consistent RCT evidence among adaptogens — multiple trials show reductions in perceived stress, anxiety, and morning cortisol. Effect sizes are modest, not clinically transformative. Rhodiola has evidence for fatigue reduction in burnout scenarios specifically.
Neither is a treatment for adrenal insufficiency, which requires corticosteroid replacement, nor are they as effective as the lifestyle interventions — sleep optimization, exercise, mind-body practices — for normalizing HPA axis function. They may add some benefit as part of a comprehensive stress management approach in people without adrenal insufficiency.
Should I test my cortisol if I’m chronically fatigued?
A morning serum cortisol is a reasonable part of a comprehensive fatigue workup, particularly with any risk factors for adrenal insufficiency present — prolonged steroid use, autoimmune conditions like Type 1 diabetes or Hashimoto’s, a history of significant head trauma or pituitary problems, family history of Addison’s disease. If morning cortisol is clearly normal (above 18 mcg/dL), the yield of further adrenal testing is low, and the focus should shift to other causes of fatigue.
Salivary cortisol testing marketed by wellness practitioners as “diagnosing adrenal fatigue” is not a validated clinical tool and shouldn’t substitute for morning serum cortisol as a screening test. A comprehensive fatigue workup should also cover: TSH, CBC, comprehensive metabolic panel, ferritin, vitamin B12, vitamin D, fasting insulin, and evaluation for sleep disorders.
Is low DHEA a sign of adrenal problems?
DHEA and its sulfated form DHEA-S decline progressively with aging — this is normal and well-documented, not pathological adrenal insufficiency. By age 70, DHEA-S levels typically run 10-20% of peak young-adulthood levels.
Very low DHEA-S for age shows up in adrenal insufficiency, as the zona reticularis fails alongside the zona fasciculata, and markedly low DHEA-S can support an adrenal insufficiency diagnosis — but it’s not a standalone diagnostic marker and should be read alongside cortisol testing, not instead of it.
DHEA supplementation has been studied extensively with largely disappointing results — trials show modest improvements in quality of life and mood in women with adrenal insufficiency already on replacement therapy, but no established benefit for the general population with ordinary age-related DHEA decline.
The HPA Axis and Immune Function: Why Cortisol Dysregulation Matters
Understanding the HPA axis’s relationship with immune regulation gives a mechanistic framework for why chronic stress produces real physiological consequences — and why the “it’s just stress” dismissal is medically inadequate even when formal adrenal insufficiency isn’t present.
Cortisol is a potent immunomodulator. At physiological concentrations, cortisol maintains immune homeostasis by suppressing excessive inflammatory responses — the reason synthetic glucocorticoids (prednisone, dexamethasone) get used to treat autoimmune diseases, inflammatory bowel disease, severe allergic reactions. This anti-inflammatory action is essential for keeping the immune system from inadvertently damaging host tissue while responding to pathogens or injury.
When cortisol is chronically elevated — prolonged psychological stress, Cushing’s syndrome, exogenous steroid use — the immune system becomes progressively dysregulated in complicated ways. Initial glucocorticoid receptor downregulation reduces the sensitivity of immune cells to cortisol’s anti-inflammatory signals, a phenomenon called glucocorticoid resistance. Paradoxically, prolonged cortisol elevation can then produce a state where the immune system is less effectively regulated despite high cortisol levels, feeding chronic low-grade inflammation.
Which may partly explain why people with chronic stress show both elevated cortisol and elevated inflammatory markers at the same time — the regulation has failed. Not just the cortisol level.
When cortisol is deficient, as in adrenal insufficiency, inflammatory processes run unchecked. This shows up clinically in untreated Addison’s disease, where patients often have elevated inflammatory cytokines, enhanced autoimmune activity, and exaggerated responses to minor infections. The clinical observation that adrenal insufficient patients do extremely poorly with infections — and why stress dosing during illness matters so much — reflects cortisol’s essential role in keeping the immune response contained to manageable levels during pathological challenges.
The immune-HPA axis crosstalk runs both directions. Cytokines produced during immune activation — particularly IL-1, IL-6, TNF-alpha — stimulate the HPA axis, raising cortisol production. This cytokine-driven cortisol response is meant to limit immune activation before it causes self-damage. In chronic inflammatory conditions — autoimmune diseases, chronic infections, cancer-related inflammation — this axis stays continuously active, driving cortisol patterns that differ from healthy-stress cortisol patterns in ways that affect fatigue, sleep, and cognitive function.
The “inflammatory fatigue” experienced by people with autoimmune diseases or cancer is substantially mediated through these HPA-immune interactions, not through some separate mechanism. Understanding this helps explain why treating the underlying inflammation often does more for fatigue than addressing the cortisol abnormalities directly.
Recognizing Adrenal Crisis Risk: Patient Education That Saves Lives
For patients with confirmed adrenal insufficiency, the education given at diagnosis about adrenal crisis recognition and management is not a routine handout. It’s potentially life-saving information that needs to be retained, reviewed, and accessible right when it’s needed most — which is often precisely when the patient feels too ill to think clearly.
Adrenal crisis is the most serious acute complication of adrenal insufficiency, and it kills people who don’t get timely treatment.
Every patient with primary or secondary adrenal insufficiency should leave their first endocrinology appointment with: a written sick day protocol with specific dose doubling/tripling instructions; an emergency injectable hydrocortisone kit (Solu-Cortef 100 mg Act-O-Vial, with training on mixing and injecting it — either self-injection IM or injection by a family member or caregiver); a medical alert bracelet or card clearly stating “Adrenal Insufficiency — Requires Hydrocortisone in Emergency”; an emergency letter from their physician explaining their condition and specific treatment needs, to show emergency medical personnel; and clear instructions to call 911 for any suspected adrenal crisis rather than trying to manage it at home.
The specific clinical scenarios that mandate stress dosing: any fever above 38°C (100.4°F); moderate-to-severe illness (influenza, GI illness with vomiting, dental procedures, minor surgery); mental or physical exhaustion from extreme conditions; and any procedure requiring general anesthesia. The general rule: double the daily hydrocortisone dose during illness; triple it for fever above 39°C or more severe illness; inject the emergency kit for vomiting that prevents oral medication absorption, and activate emergency services right away.
Emergency personnel awareness is a persistent challenge. A lot of emergency department providers are less familiar with adrenal crisis management than they should be — it’s an uncommon condition, and the presentation (hypotension, altered consciousness, abdominal pain, hypoglycemia) overlaps with other emergencies. Patients and families who can clearly communicate the diagnosis, present documentation, and specifically request “100 mg IV hydrocortisone for adrenal crisis” may need to advocate actively in emergency settings, particularly at smaller hospitals with less endocrine specialty support.
This advocacy isn’t combative. It’s providing critical diagnostic context that speeds appropriate treatment and improves outcomes. Medical alert bracelets remain the most universally understood signal to emergency personnel that a patient has a specific hormonal emergency requiring targeted treatment.
The Practical Framework: Applying Adrenal Glands Anatomy Physiology In Real Life
References
Editorial StandardsCorrectionsMedical DisclaimerAbout Our ContentAffiliate DisclosureSite Map